Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? (Q38064659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

review article

1 reference

title

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

main subject

mesenchymal stem cell

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Aideen E Ryan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Oliver Treacy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Thomas Ritter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Senthilkumar Alagesan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Paul Lohan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

1 reference

4 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

40-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

History of clinical transplantation

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Transplantation and its biology: from fantasy to routine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mechanisms of rejection: current perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Rejection of the kidney allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The impact of infection and tissue damage in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Monitoring and treating posttransplant human leukocyte antigen antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The spectrum of antibody-mediated renal allograft injury: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The promise of induced pluripotent stem cells in research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Immunological aspects of allogeneic mesenchymal stem cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Therapeutic applications of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cell therapy: Two steps forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Why are MSCs therapeutic? New data: new insight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stromal cells: a key player in 'innate tolerance'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Pathways of major histocompatibility complex allorecognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cell effects on T-cell effector pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Therapeutic potential of mesenchymal stem cell-derived microvesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mechanisms of alloantibody production in sensitized renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Immunomodulatory effect of mesenchymal stem cells on B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The role of natural killer cells in human solid organ and tissue transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Current perspectives of natural killer cell education by MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

The complementary roles of deletion and regulation in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Post-transplantation antibody monitoring and HLA antibody epitope identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Immunogenicity of allogeneic mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Optimizing mesenchymal stem cell-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stromal cell 'licensing': a multistep process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cells and their potential as cardiac therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Current trends in mesenchymal stem cell application in bone augmentation: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Clinical applications of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

Graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Pharma's developing interest in stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

The B-cell response to protein antigens in immunity and transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Immunogenicity of umbilical cord tissue derived cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.67

7 January 2021

Identifiers

DOI

10.1038/ICB.2012.67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207278%20AND%20SRC:MED&resulttype=core&format=json